title: Selective removal of human serum amyloid P component from rat blood by use of an immunoaffinity membrane in an extracorporeal circulation system.
abstract: We examined the suitability of an immunoaffinity membrane (IAM) bearing specific antibody as a ligand for removing human serum amyloid P component (hSAP) from blood passed through a simple extracorporeal circulation system established in rats. The specific antibody was the most effective of the various ligands tested for removing hSAP from human blood. To determine the value of the hSAP in human or rat plasma, we also developed a simple ELISA. In the rat extracorporeal circulation system, the hSAP level in the inlet blood to the IAM module decreased to 49% of the initial concentration within 60 min. In contrast, the hSAP remained at the initial concentration throughout the study in the module without the IAM. The use of this extracorporeal circulation system in this case allows preclinical evaluation of the ex vivo removal of a human plasma component in an animal model. Biocompatibility of the IAM was also examined. No change in blood cell counts or activation of the coagulation system occurred after contact with the IAM. Non-specific adsorption was not observed, since there was no statistically significant difference in IgG, complement C3, or albumin level between the pre- and post-treatment with this module. The immunological effects of the IAM were also examined using this system. Four weeks after the termination of the extracorporeal circulation, the rats examined showed no detectable antibody titer to the ligand.
authors.affiliation: Hatano Research Institute, Food and Drug Safety Center, Kanagawa, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Adachi
authors.forename: M
authors.initials: M
authors.lastname: Mogi
authors.forename: M
authors.initials: M
authors.lastname: Harada
authors.forename: K
authors.initials: K
authors.lastname: Kojima
mesh_terms: D000327:Adsorption; D000818:Animals; D001772:Blood Cell Count; D001798:Blood Proteins / Q000276:immunology / Q000302:isolation & purification*; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D005112:Extracorporeal Circulation; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D007164:Immunosorbents / Q000276:immunology; D008567:Membranes, Artificial; D011817:Rabbits; D051381:Rats; D000683:Serum Amyloid P-Component / Q000276:immunology / Q000302:isolation & purification*; D013997:Time Factors
chemical_list: D001798:Blood Proteins; D007106:Immune Sera; D007164:Immunosorbents; D008567:Membranes, Artificial; D000683:Serum Amyloid P-Component